Trial Into Antioxidant for Parkinson’s Disease Yields Disappointing Results

Trial Into Antioxidant for Parkinson’s Disease Yields Disappointing Results

The research team found no significant difference in the rate of disease progression for those given the metabolite inosine for two years compared to the placebo group. Read full article here

The research team found no significant difference in the rate of disease progression for those given the metabolite inosine for two years compared to the placebo group.

Read full article here

admin
ADMINISTRATOR
PROFILE

Posts Carousel

Leave a Comment

Your email address will not be published. Required fields are marked with *